FDA & CDC Actions on “Updated Boosters”
The U.S. Food and Drug Administration (FDA) recently amended the emergency use authorizations (EUAs) of the Pfizer-BioNTech and Moderna COVID-19 Vaccines “to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following …
